Cargando…
Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis
INTRODUCTION: The combination of hydralazine–isosorbide dinitrate (H-ISDN) has potential as a heart failure (HF) therapy in the setting of maintenance dialysis. METHODS: In this retrospective study, we analyzed the efficacy of H-ISDN using United States Renal Data System (USRDS) data. We identified...
Autores principales: | Mavrakanas, Thomas A., Soomro, Qandeel H., Charytan, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171697/ https://www.ncbi.nlm.nih.gov/pubmed/35685328 http://dx.doi.org/10.1016/j.ekir.2022.03.032 |
Ejemplares similares
-
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
por: Echols, Melvin R, et al.
Publicado: (2006) -
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross‐European survey
por: Brewster, Lizzy M.
Publicado: (2019) -
Eco-friendly estimation of isosorbide dinitrate and hydralazine hydrochloride using Green Analytical Quality by Design-based UPLC Method
por: Chanduluru, Hemanth Kumar, et al.
Publicado: (2021) -
Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for detection of obstruction in hypertrophic cardiomyopathy
por: Zemanek, David, et al.
Publicado: (2015) -
Coronary MRI with induced vasodilation using isosorbide dinitrate
por: Hu, Peng, et al.
Publicado: (2009)